4D Molecular Therapeutics Inc (FDMT)
9.96
-0.38
(-3.68%)
USD |
NASDAQ |
Oct 04, 16:00
9.98
+0.02
(+0.20%)
After-Hours: 20:00
4D Molecular Therapeutics Shareholders Equity (Annual): 307.83M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 307.83M |
December 31, 2022 | 231.34M |
December 31, 2021 | 319.11M |
December 31, 2020 | 256.39M |
Date | Value |
---|---|
December 31, 2019 | -72.97M |
December 31, 2018 | -27.59M |
December 31, 2017 | -19.59M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
-72.97M
Minimum
2019
319.11M
Maximum
2021
208.34M
Average
256.39M
Median
2020
Shareholders Equity (Annual) Benchmarks
Johnson & Johnson | 68.77B |
Regeneron Pharmaceuticals Inc | 25.97B |
Journey Medical Corp | 20.35M |
NovaBay Pharmaceuticals Inc | 3.314M |
Palatin Technologies Inc | -0.1115M |